Chédiak-Higashi and Griscelli syndromes

Immunology and Allergy Clinics of North America

Volumn 22, Issue 2, 2002, Pages 301-317

  De Saint Basile, Geneviève ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYTOTOXIC AGENT; ETOPOSIDE; THYMOCYTE ANTIBODY;

CHEDIAK HIGASHI SYNDROME; CLINICAL FEATURE; GRISCELLI SYNDROME; HOMEOSTASIS; HUMAN; LYMPHOCYTE; MOLECULAR BIOLOGY; MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

EID: 0036317696     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(01)00003-0     Document Type: Review

References (96)

1. Genetic basis of hemophagocytic lymphohistiocytosis syndrome
2. Hemophagocytic lymphohistiocytosis: Diagnosis, treatment and pronostic factors. Report of 122 children from the international registry
3. Familial hemophagocytic lymphohistiocytosis: Primary hemophagocytic lymphohistiocytosis
4. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis
5. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis
6. Perforin gene defects in familial hemophagocytic lymphohistiocytosis
7. Perforin: More than just an effector molecule
8. Identification of the homologous beige and Chédiak-Higashi syndrome genes
9. Identification and mutation analysis of the complete gene for Chédiak-Higashi syndrome
10. The Beige/Chédiak-Higashi syndrome gene encodes a widely expressed cytosolic protein
11. Loss of cytotoxic T lymphocyte function in Chédiak-Higashi syndrome arise from a secretory defect that prevents lytic granule exocytosis
12. Mutations in RAB27A cause Griscelli syndrome associated with hemophagocytic syndrome
13. + T cells by perforin
14. A role for perforin in downregulating T-cell responses during chronic viral infection
15. Compromised virus control and augmented perforin-mediated immunopathology in IFN-γ-deficient mice infected with lymphocytic choriomeningitis virus
16. + T cells derived from TNF-deficient and TNF/perforin double-deficient mice
17. Localization dose and time of antigens determine immune reactivity
18. Partial engraftment of donor bone marrow cells associated with long-term remission of haemophagocytic lymphohistiocytosis
19. TCR-mediated internalization of peptide-MHC complexes acquired by T cells
20. Cutting edge: CTLs rapidly capture membrane fragments from target cells in a TCR signaling-dependent manner
21. Chédiak-Higashi syndrome: Description of a cluster in a Venezuelan-Andean isolated region
22. Neutropenia cronica maligna familiar con granulaciones atipicas de los leucocitos
23. The Chédiak-Higashi syndrome: Studies in four patients and a review of the literature
24. A human pigmentary dilution based on a heritable subcellular structural defect-the Chédiak-Higashi syndrome
25. Ocular manifestations of the Chédiak Higashi syndrome
26. Histopathology of eyes in Chédiak-Higashi syndrome
27. Pigmentary changes in Chédiak-Higashi syndrome: Microscopic study of 12 homozygous and heterozygous subjects
28. Chédiak-Higashi syndrome: Report of a case and review of the Japanese literature
29. The Chédiak-Higashi syndrome: Formation of giant melanosomes and the basis of hypopigmentation
30. The Chédiak-Higashi syndrome: A possible lysosomal disease
31. The giant organelles in beige and Chediak-Higashi fibroblasts are derived from late endosomes and mature lysosomes
32. Chédiak-Higashi lymphoblastoid cell lines: Granule characteristics and expression of lysosome-associated membrane proteins
33. Chédiak-Higashi gene in humans: I. Impairment of natural killer function
34. Deficiency of active natural killer cells in the Chédiak-Higashi syndrome: Localization of the defect using a single cell cytotoxicity assay
35. Chédiak-Higashi gene in humans: II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function
36. A new immunodeficiency disorder in humans involving NK cells
37. Peripheral neuropathy in the Chédiak-Higashi syndrome
38. Adult Chédiak-Higashi syndrome presenting as parkinsonism and dementia
39. Beige rat: A new animal model of Chédiak-Higashi syndrome
40. Animal model of human disease: Chédiak-Higashi syndrome
41. The Chédiak-Higashi syndrome and the homologous trait in animals
42. Nidogen/entactin (Nid) maps to the proximal end of mouse chromosome 13 linked to beige (bg) and identifies a new region of homology between mouse and human chromosomes
43. Genetic and physical mapping of the Chédiak-Higashi syndrome on chromosome 1q42-43
44. Homozygosity mapping of the gene for the Chédiak-Higashi syndrome to 1q42-q44 in a segment of conserved syntheny that includes the mouse beige locus (bg)
45. Identification of the murine beige gene by YAC complementation and positional cloning
46. Identification of mutations in two major mRNA isoforms of the Chediak-Higashi syndrome gene in human and mouse
47. Mutations in the Chédiak-Higashi syndrome gene (CHS1) indicate requirement for the complete 3801 amino acid CHS protein
48. A repeating amino acid motif shared by proteins with diverse cellular roles
49. HEAT repeats in the Huntington's disease protein
50. Folding of proteins with WD-repeats: Comparison of six members of the WD-repeat superfamily to the G protein β subunit
51. The ancient regulatory-protein family of WD-repeat proteins
52. A membrane-associated complex containing the Vps15 protein kinase and the Vps34 PI 3-kinase is essential for protein sorting to the yeast lysosome-like vacuole
53. Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: The Chediak-Higashi syndrome
54. Enhanced interaction of HLA-DM with HLA-DR in enlarged vacuoles of hereditary and infectious lysosomal diseases
55. Secretory lysosome biogenesis in cytotoxic T lymphocytes from normal and Chédiak Higashi syndrome patients
56. Defective CTLA-4 cycling pathway in Chédiak Higashi syndrome: A possible mechanism for deregulation of T lymphocyte activation
57. Protein truncation test of LYST reveals heterogenous mutations in patients with Chédiak-Higashi syndrome
58. A syndrome associating partial albinism and immunodeficiency
59. Partial albinism with immunodeficiency: Griscelli syndrome. Report of a case and review of the literature
60. Griscelli syndrome: Report of three cases
61. Griscelli disease with cerebral involvement
62. Partial albinism, immunodeficiency, and progressive white matter disease: A new primary immunodeficiency
63. A kindred with Griscelli disease: Spectrum of neurological involvement
64. Partial albinism with immunodeficiency (Griscelli syndrome)
65. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene
66. Two genes are responsible for Griscelli syndrome at the same 15q21 locus
67. Bone marrow transplantation (BMT) for the syndrome of pigmentary dilution and lymphohistiocytosis (Griscelli's syndrome)
68. Successful bone marrow transplantation in a case of Griscelli disease which presented in accelerated phase with neurological involvement
69. Human herpesvirus-6 (HHV-6)-associated necrotizing encephalitis in Griscelli's syndrome
70. + store in the dendritic spine of Purkinje cells in mice
71. An allelic variant of Griscelli disease: Presentation with severe hypotonia, mental-motor retardation, and hypopigmentation consistent with Elejalde syndrome (neuroectodermal melanolysosomal disorder)
72. Mutations affecting Pigmentation in Man: I. Neuroectodermal melanolysosomal disease
73. Novel myosin heavy chain encoded by murine dilute coat colour locus
74. Myosins: Myosin V-the multi-purpose transport motor
75. A mutation in Rab27a causes the vesicle transport defects observed in ashen mice
76. Myosin V associates with melanosomes in mouse melanocytes: Evidence that myosin V is an organelle motor
77. +-dependent interaction with the synaptobrevin-synaptophysin complex
78. Molecular cloning and characterization of rab27a and rab27b, novel human rab proteins shared by melanocytes and platelets
79. Rab27A: A key to melanosome transport in human melanocytes
80. Brain Myosin-V is a two-headed unconventional myosin with motor activity
81. Molecular genetic dissection of mouse unconventional myosin-VA: Tail region mutations
82. Human myosin V gene produces different transcripts in a cell type-specific manner
83. Cultured melanocytes from dilute mutant mice exhibit dendritic morphology and altered melanosome distribution
84. Endoplasmic reticulum is missing in dendritic spines of Purkinje cells of the ataxic mutant rat
85. Dilute (d) coat colour mutation of DBA/2J mice is associated with the site of integration of an ecotropic MuLV genome
86. Defective granule exocytosis in rab27a-deficient lymphocytes from ashen mice
87. Rab27a is required for regulated secretion in cytotoxic T lymphocytes
88. Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity
89. Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epidophyllotoxin VP16-213
90. Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of VP16-213, steroids, intrathecal methotrexate and cranial irradiation
91. Treatment of hemophagocytic lymphohistiocytosis with chemotherapy and bone marrow transplantation: A single-center study of 22 cases
92. Familial erythrophagocytic reticulosis: Complete response to combination chemotherapy
93. Familial erythrophagocytic lymphohistiocytosis: Late relapse despite continuous high-dose VP-16 chemotherapy
94. Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A
95. Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors
96. Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis